Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-185.82M
↓ 134% below average
Average (6y)
$-79.42M
Historical baseline
Range
High:$-774000.00
Low:$-185.82M
CAGR
+149.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-185.82M | -22.1% |
| 2023 | $-152.18M | -46.3% |
| 2022 | $-104.00M | -84.6% |
| 2021 | $-56.35M | -25.4% |
| 2020 | $-44.92M | -277.8% |
| 2019 | $-11.89M | -1436.2% |
| 2018 | $-774000.00 | - |